Jiuzhitang Co., Ltd. logo

Jiuzhitang Co., Ltd. (000989)

Market Open
10 Aug, 06:57
XSHE XSHE
¥
9. 50
+0.02
+0.211%
¥
8.09B Market Cap
- P/E Ratio
1.2% Div Yield
49.31M Volume
- Eps
¥ 9.48
Previous Close
Add Transaction
Day Range
9.01 9.65
Year Range
7.4 12.93
Want to track 000989 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

000989 trading today higher at ¥9.5, an increase of 0.211% from yesterday's close, completing a monthly increase of 22.5806% or ¥1.75. Over the past 12 months, 000989 stock gained 8.6957%.
000989 pays dividends to its shareholders, with the most recent payment made on May 14, 2026. The next estimated payment will be in In 9 months on May 14, 2027 for a total of ¥0.3.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.1377%. On average, the company has surpassed earnings expectations by 0.1193%, based on the last three reports.
Jiuzhitang Co., Ltd. has completed 4 stock splits, with the recent split occurring on May 27, 2016.
The company's stock is traded on one exchange.

000989 Chart

People also search for

Dr Corp Ltd.
¥ 23.68
-1.0447%
Sunvim Group Co., Ltd.
¥ 11.97
-1.2376%
Tibet Gaozheng Explosive Co., Ltd.
¥ 59
-0.9735%
Innovative Medical Management Co., Ltd.
¥ 21.68
-1.0949%
Henan Liliang Diamond Co., Ltd.
¥ 58.62
-2.3488%

Jiuzhitang Co., Ltd. (000989) FAQ

What is the stock price today?

The current price is ¥9.50.

On which exchange is it traded?

Jiuzhitang Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000989.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.2%.

What is its market cap?

As of today, the market cap is 8.09B.

Has Jiuzhitang Co., Ltd. ever had a stock split?

Jiuzhitang Co., Ltd. had 4 splits and the recent split was on May 27, 2016.

Jiuzhitang Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Li Zhen Guo CEO
XSHE Exchange
CNE000001394 ISIN
CN Country
3,689 Employees
14 May 2026 Last Dividend
27 May 2016 Last Split
9 Jun 2000 IPO Date

Overview

Jiuzhitang Co., Ltd. is a distinguished provider of a broad spectrum of medicinal products within China, specializing in the realms of traditional Chinese, chemical, biological, and health medicines. Founded in 1999 and headquartered in Beijing, the company has cemented its reputation for delivering a wide array of treatments targeting various health concerns, ranging from cardiovascular and neurological conditions to gynecology, ENT diseases, and liver disorders. In addition to its prescription drugs, Jiuzhitang Co., Ltd. also caters to the general public with over-the-counter (OTC) drugs and innovative treatments such as stem cell therapies.

Products and Services

Prescription Medications:

  • Shuxuetong injections, Angong Niuhuang pills, Gastrodia Gouteng granules, Danxi granules, and Compound Jiangzhi tablets are designed for cardiovascular and neurological treatments.
  • Nudehua Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Analgesic capsules cater to the needs in gynecology.
  • Houyan pills target ear, nose, and throat (ENT) diseases.
  • Jianwei Yuyang tablets are for improving digestion.
  • Jiaqi Ganxian granules and Chidan Tuihuang granules are specialized formulations for liver diseases.

Over-the-counter (OTC) Drugs:
Jiuzhitang Co., Ltd. provides a broad range of OTC medications suited for:

  • Blood-tonifying
  • Cardiovascular and cerebrovascular
  • Urinary system
  • Pediatric
  • Gynecologic
  • Bone and muscles
  • Respiratory system
  • Dermatologic
  • Nervous system
  • ENT
  • Digestive system
These products cater to a wide array of health conditions, offering accessible treatment options to the broader population.

Stem Cell and Other Treatments:
In addition to its traditional and chemical-based medicines, Jiuzhitang Co., Ltd. is at the forefront of biomedical advancements, offering stem cell therapies and other innovative drugs. These treatments represent the company’s commitment to leveraging scientific research for improving patient health outcomes.

Contact Information

Address: Chaoyang Sports Center, Beijing, China, 100026
Phone: 86 10 8468 3155